Clinical Trial Update: Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of a fixed-dose combination of valsartan and hydrochlorothiazide in hypertensive patients not controlled by a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Diovan HCT (valsartan/hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED